Exhibit 107

 

Calculation of Filing Fee Table

 

Form S-1

(Form Type)

 

MIRA PHARMACEUTICALS, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

  

Security

Type

 

Security Class

Title

 

Fee

Calculation

or Carry

Forward

Rule

 

Maximum Aggregate

Offering Price (1)(2)

   Fee Rate  

Amount of

Registration Fee

 
Fees Previously Paid  Equity  Common stock, par value $0.0001 per share (3)  457(o)  $16,400,000    0.00011020   $1,807.28 
   Equity  Underwriter Warrants (4)  457(g)   —    —    — 
Fees Previously Paid  Equity  Common stock issuable upon exercise of Underwriter Warrants (5)  457(o)   600,000    0.00011020    66.12 
Secondary Offering  Equity   Common stock, par value $0.0001 per share      11,000,000    0.00011020    1,212.20 
                         
      Total Offering Amounts     $28,000.000        $3,085.60 
      Total Fees Previously Paid               $1,873.40 
      Total Fee Offsets               $— 
      Net Fee Due               $1,212.20 

 

  (1) Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) of the Securities Act of 1933, as amended. Includes shares to be sold upon exercise of the underwriters’ option to purchase additional shares.
  (2) Pursuant to Rule 416, the securities being registered hereunder include such indeterminate number of additional securities as may be issued after the date hereof as a result of stock splits, stock dividends or similar transactions.
  (3) Includes shares of common stock which may be issued on exercise of a 45-day option granted to the underwriters to cover over-allotments.
  (4) No fee pursuant to Rule 457(g) under the Securities Act of 1933, as amended.
  (5) As estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o), the proposed maximum aggregate offering price of the Underwriter Warrants is $600,000, which is equal to 5.0% of the aggregate number of shares of common stock sold in this offering, excluding the overallotment option, at an exercise price equal to 100% of the public offering price per share.